Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "jobs"

140 News Found

Vetter to invest €480 million in major German manufacturing expansion, eyes 2,000 jobs
News | January 30, 2026

Vetter to invest €480 million in major German manufacturing expansion, eyes 2,000 jobs

The state-of-the-art commercial production plant will be built on a 95-acre site in Saarlouis, acquired at the end of 2024


Novo Nordisk to cut 9,000 jobs globally
News | September 11, 2025

Novo Nordisk to cut 9,000 jobs globally

Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients


Lonza to set up Global Capability Centre in Hyderabad
News | March 06, 2026

Lonza to set up Global Capability Centre in Hyderabad

Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process


CordenPharma expands boulder presence with 64,000-Sq-Ft Lease at BioMed Realty’s Flatiron Park
News | March 06, 2026

CordenPharma expands boulder presence with 64,000-Sq-Ft Lease at BioMed Realty’s Flatiron Park

The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant


Novo Nordisk invests €432 million to expand Athlone facility for global Wegovy pill supply
News | March 02, 2026

Novo Nordisk invests €432 million to expand Athlone facility for global Wegovy pill supply

The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202


Blue Jet Healthcare breaks ground on Rs. 2,300 crore pharma plant in Andhra Pradesh
News | March 02, 2026

Blue Jet Healthcare breaks ground on Rs. 2,300 crore pharma plant in Andhra Pradesh

The facility is expected to become operational by FY2028-29


Novartis’ remibrutinib bags positive CHMP opinion for chronic urticaria
Clinical Trials | February 28, 2026

Novartis’ remibrutinib bags positive CHMP opinion for chronic urticaria

The oral therapy is aimed at adults with chronic spontaneous urticaria (CSU) who do not respond adequately to H1-antihistamines


£1bn London Cancer Hub expansion wins planning approval
R&D | February 07, 2026

£1bn London Cancer Hub expansion wins planning approval

The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site